Milestone Historical Income Statement

MLSS Stock

USD 0.72 0.09 11.11%

Historical analysis of Milestone Scientific income statement accounts such as Total Revenue of 7.9 M can show how well Milestone Scientific performed in making a profits. Evaluating Milestone Scientific income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Milestone Scientific's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Milestone Scientific latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Milestone Scientific is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.

About Milestone Income Statement Analysis

Milestone Scientific Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Milestone Scientific shareholders. The income statement also shows Milestone investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Milestone Scientific Income Statement Chart

At this time, Milestone Scientific's Total Other Income Expense Net is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 3.5 M in 2024, whereas Interest Expense is likely to drop slightly above 59.7 K in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses Income Tax Expense Non Recurring

Total Revenue

Total revenue comprises all receipts Milestone Scientific generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Milestone Scientific minus its cost of goods sold. It is profit before Milestone Scientific operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Milestone Scientific. It is also known as Milestone Scientific overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Milestone Scientific's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Milestone Scientific current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Milestone Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Milestone Stock please use our How to Invest in Milestone Scientific guide.At this time, Milestone Scientific's Total Other Income Expense Net is comparatively stable compared to the past year. Cost Of Revenue is likely to gain to about 3.5 M in 2024, whereas Interest Expense is likely to drop slightly above 59.7 K in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	6.3M	4.9M	6.7M	4.5M
Total Revenue	10.3M	8.8M	9.8M	7.9M

Gross Profit Total Revenue

Milestone Scientific income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Cost Of Revenue	Net Income From Continuing Ops	Non Operating Income Net Other	Selling And Marketing Expenses	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Non Recurring
Depreciation And Amortization		0.97	0.09	0.01	0.03	0.03	-0.03	0.01	-0.19	0.33	0.05	-0.31	-0.93	-0.3	0.12	-0.07	-0.31	-0.71	0.12	0.02	0.0	-0.3	-0.14	-0.08	0.12
Interest Expense	0.97		0.02	-0.02	0.06	-0.04	0.06	0.06	-0.17	0.36	-0.01	-0.23	-0.88	-0.23	0.1	-0.21	-0.23	-0.77	0.09	0.06	0.0	-0.43	-0.12	-0.2	0.09
Selling General Administrative	0.09	0.02		0.59	0.49	0.98	-0.8	-0.82	0.62	-0.74	0.99	-0.78	-0.06	-0.8	0.44	0.54	-0.8	0.15	-0.09	-0.23	-0.73	0.49	0.25	-0.46	-0.09
Total Revenue	0.01	-0.02	0.59		0.95	0.7	-0.09	-0.1	0.23	-0.09	0.56	-0.09	-0.07	-0.11	0.22	0.75	-0.14	-0.09	0.01	-0.22	-0.26	0.16	0.03	0.08	0.01
Gross Profit	0.03	0.06	0.49	0.95		0.56	0.1	0.03	0.13	0.04	0.46	0.07	-0.04	0.02	0.14	0.51	0.02	-0.24	0.03	-0.14	-0.16	0.04	0.01	-0.02	0.03
Other Operating Expenses	0.03	-0.04	0.98	0.7	0.56		-0.76	-0.75	0.65	-0.7	0.97	-0.73	-0.04	-0.72	0.41	0.69	-0.75	0.19	-0.1	-0.29	-0.73	0.47	0.24	-0.33	-0.1
Operating Income	-0.03	0.06	-0.8	-0.09	0.1	-0.76		0.96	-0.65	0.9	-0.82	0.95	0.01	0.93	-0.38	-0.36	0.95	-0.39	0.28	0.19	0.79	-0.53	-0.4	0.48	0.28
Ebit	0.01	0.06	-0.82	-0.1	0.03	-0.75	0.96		-0.73	0.95	-0.85	0.92	-0.09	0.9	-0.33	-0.25	0.92	-0.37	0.32	0.17	0.85	-0.49	-0.45	0.65	0.32
Research Development	-0.19	-0.17	0.62	0.23	0.13	0.65	-0.65	-0.73		-0.75	0.69	-0.57	0.28	-0.51	0.08	0.35	-0.57	0.33	-0.1	-0.48	-0.89	0.08	0.25	-0.44	-0.1
Ebitda	0.33	0.36	-0.74	-0.09	0.04	-0.7	0.9	0.95	-0.75		-0.78	0.77	-0.38	0.76	-0.27	-0.26	0.76	-0.58	0.34	0.16	0.81	-0.56	-0.47	0.59	0.34
Total Operating Expenses	0.05	-0.01	0.99	0.56	0.46	0.97	-0.82	-0.85	0.69	-0.78		-0.79	-0.01	-0.8	0.41	0.52	-0.81	0.19	-0.11	-0.26	-0.78	0.48	0.28	-0.48	-0.11
Income Before Tax	-0.31	-0.23	-0.78	-0.09	0.07	-0.73	0.95	0.92	-0.57	0.77	-0.79		0.28	0.98	-0.44	-0.3	1.0	-0.15	0.28	0.17	0.76	-0.39	-0.38	0.52	0.28
Total Other Income Expense Net	-0.93	-0.88	-0.06	-0.07	-0.04	-0.04	0.01	-0.09	0.28	-0.38	-0.01	0.28		0.26	-0.27	-0.05	0.28	0.67	-0.18	0.0	-0.11	0.32	0.19	-0.09	-0.18
Net Income	-0.3	-0.23	-0.8	-0.11	0.02	-0.72	0.93	0.9	-0.51	0.76	-0.8	0.98	0.26		-0.48	-0.26	0.98	-0.06	0.27	0.12	0.71	-0.37	-0.37	0.53	0.27
Income Tax Expense	0.12	0.1	0.44	0.22	0.14	0.41	-0.38	-0.33	0.08	-0.27	0.41	-0.44	-0.27	-0.48		0.22	-0.44	-0.01	-0.03	-0.1	-0.2	0.13	0.03	-0.1	-0.03
Cost Of Revenue	-0.07	-0.21	0.54	0.75	0.51	0.69	-0.36	-0.25	0.35	-0.26	0.52	-0.3	-0.05	-0.26	0.22		-0.33	0.23	-0.01	-0.32	-0.34	0.32	0.03	0.32	-0.01
Net Income From Continuing Ops	-0.31	-0.23	-0.8	-0.14	0.02	-0.75	0.95	0.92	-0.57	0.76	-0.81	1.0	0.28	0.98	-0.44	-0.33		-0.14	0.29	0.17	0.77	-0.39	-0.39	0.51	0.29
Non Operating Income Net Other	-0.71	-0.77	0.15	-0.09	-0.24	0.19	-0.39	-0.37	0.33	-0.58	0.19	-0.15	0.67	-0.06	-0.01	0.23	-0.14		-0.26	0.06	-0.28	0.66	0.32	-0.12	-0.26
Selling And Marketing Expenses	0.12	0.09	-0.09	0.01	0.03	-0.1	0.28	0.32	-0.1	0.34	-0.11	0.28	-0.18	0.27	-0.03	-0.01	0.29	-0.26		-0.18	0.38	-0.2	-0.9	0.33	1.0
Minority Interest	0.02	0.06	-0.23	-0.22	-0.14	-0.29	0.19	0.17	-0.48	0.16	-0.26	0.17	0.0	0.12	-0.1	-0.32	0.17	0.06	-0.18		0.48	0.37	0.22	-0.31	-0.18
Tax Provision	0.0	0.0	-0.73	-0.26	-0.16	-0.73	0.79	0.85	-0.89	0.81	-0.78	0.76	-0.11	0.71	-0.2	-0.34	0.77	-0.28	0.38	0.48		-0.16	-0.45	0.54	0.38
Interest Income	-0.3	-0.43	0.49	0.16	0.04	0.47	-0.53	-0.49	0.08	-0.56	0.48	-0.39	0.32	-0.37	0.13	0.32	-0.39	0.66	-0.2	0.37	-0.16		0.34	-0.22	-0.2
Net Interest Income	-0.14	-0.12	0.25	0.03	0.01	0.24	-0.4	-0.45	0.25	-0.47	0.28	-0.38	0.19	-0.37	0.03	0.03	-0.39	0.32	-0.9	0.22	-0.45	0.34		-0.41	-0.9
Reconciled Depreciation	-0.08	-0.2	-0.46	0.08	-0.02	-0.33	0.48	0.65	-0.44	0.59	-0.48	0.52	-0.09	0.53	-0.1	0.32	0.51	-0.12	0.33	-0.31	0.54	-0.22	-0.41		0.33
Non Recurring	0.12	0.09	-0.09	0.01	0.03	-0.1	0.28	0.32	-0.1	0.34	-0.11	0.28	-0.18	0.27	-0.03	-0.01	0.29	-0.26	1.0	-0.18	0.38	-0.2	-0.9	0.33

Click cells to compare fundamentals

Milestone Scientific Account Relationship Matchups

Milestone Scientific income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	3.9M	130.3K	128.9K	144.4K	150.4K	142.8K
Interest Expense	7.1M	18.1K	16.4K	54.6K	62.8K	59.7K
Selling General Administrative	9.5M	10.8M	12.7M	12.5M	12.7M	8.5M
Total Revenue	8.4M	5.4M	10.3M	8.8M	9.8M	7.9M
Gross Profit	5.7M	3.6M	6.3M	4.9M	6.7M	4.5M
Other Operating Expenses	12.4M	12.9M	17.7M	17.6M	16.9M	12.5M
Operating Income	(4.0M)	(7.5M)	(7.4M)	(8.8M)	(7.1M)	(6.8M)
Ebit	(4.0M)	(7.5M)	(7.4M)	(8.8M)	(7.1M)	(6.8M)
Research Development	189.9K	307.9K	878.2K	1.2M	701.4K	434.0K
Ebitda	(106.9K)	(7.4M)	(7.3M)	(8.7M)	(7.0M)	(6.6M)
Total Operating Expenses	9.7M	11.1M	13.7M	13.7M	13.8M	9.1M
Income Before Tax	(7.6M)	(7.5M)	(7.1M)	(8.8M)	(7.0M)	(7.3M)
Total Other Income Expense Net	(3.6M)	(18.1K)	259.8K	54.6K	125.5K	131.8K
Net Income	(7.7M)	(7.5M)	(7.1M)	(8.7M)	(6.9M)	(7.3M)
Income Tax Expense	18.1K	15.5K	333.0	(66.7K)	(51.8K)	(49.3K)
Cost Of Revenue	2.7M	1.8M	4.0M	3.9M	3.1M	3.5M
Net Income From Continuing Ops	(7.7M)	(7.4M)	(6.9M)	(8.8M)	(7.0M)	(7.4M)
Non Operating Income Net Other	(116.1K)	215.0	(3.6M)	73.1K	65.8K	69.1K
Net Income Applicable To Common Shares	(7.4M)	(7.5M)	(7.3M)	(6.8M)	(6.1M)	(6.4M)
Minority Interest	(55.9K)	(94.4K)	58.1K	66.7K	46.7K	49.0K
Tax Provision	19.1K	24.0K	18.1K	15.5K	333.0	0.0
Interest Income	9.3K	7.4K	1.5K	6.7K	7.7K	5.5K
Net Interest Income	1.5K	6.7K	(16.4K)	54.6K	130.5K	137.0K
Reconciled Depreciation	256.5K	95.9K	73.8K	144.4K	153.4K	249.0K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Milestone Stock Analysis

When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Milestone Historical Income Statement

About Milestone Income Statement Analysis

Milestone Scientific Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Milestone Scientific income statement Correlations

Milestone Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Milestone Scientific income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Milestone Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income From Continuing Ops	+ 1.0	Income Before Tax
Non Recurring	+ 1.0	Selling And Marketing Expenses
Total Operating Expenses	+ 0.99	Selling General Administrative
Other Operating Expenses	+ 0.98	Selling General Administrative
Net Income	+ 0.98	Income Before Tax
Net Income From Continuing Ops	+ 0.98	Net Income

Total Other Income Expense Net	- 0.93	Depreciation And Amortization
Non Recurring	- 0.9	Net Interest Income
Net Interest Income	- 0.9	Selling And Marketing Expenses
Tax Provision	- 0.89	Research Development
Total Other Income Expense Net	- 0.88	Interest Expense
Total Operating Expenses	- 0.85	Ebit